According to ScienceDaily, people prescribed GLP-1 medications like Ozempic for type 2 diabetes often stop taking them—but many don't stay off the drugs for long. A new study shows that while side effects remain the leading reason patients discontinue treatment, newer medications are proving more effective at keeping people engaged with their therapy long-term.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton